The estimated Net Worth of Mark Daniels is at least $13.5 Million dollars as of 31 March 2021. Mr. Daniels owns over 1,167 units of Twist Bioscience Corp stock worth over $3,020,605 and over the last 6 years he sold TWST stock worth over $9,792,101. In addition, he makes $703,972 as Senior Vice President, Chief Legal Officer und Chief Ethics and Compliance Officer and Secretary at Twist Bioscience Corp.
Mark has made over 20 trades of the Twist Bioscience Corp stock since 2019, according to the Form 4 filled with the SEC. Most recently he exercised 1,167 units of TWST stock worth $31,112 on 31 March 2021.
The largest trade he's ever made was selling 70,475 units of Twist Bioscience Corp stock on 15 December 2020 worth over $9,349,918. On average, Mark trades about 4,573 units every 18 days since 2018. As of 31 March 2021 he still owns at least 68,093 units of Twist Bioscience Corp stock.
You can see the complete history of Mr. Daniels stock trades at the bottom of the page.
Mark Daniels J.D. serves as Senior Vice President, Chief Legal Officer, Chief Ethics and Compliance Officer and Secretary of the Company. Prior to joining us, from January 2013 to May 2016, Mr. Daniels was at Broadcom Corporation, a semiconductor manufacturer and producer of wireless and broadband products, where his most recent position was Vice President, Law and Deputy Chief Corporate Compliance Officer. Before that, he spent 20 years in positions of increasing responsibility in the legal department at Amgen, Inc., a producer of biopharmaceuticals, where his last role was Vice President and Associate General Counsel. Mr. Daniels received his B.S. with honors in Industrial and Labor Relations from Cornell University and a J.D., cum laude, from Harvard Law School.
As the Senior Vice President, Chief Legal Officer und Chief Ethics and Compliance Officer and Secretary of Twist Bioscience Corp, the total compensation of Mark Daniels at Twist Bioscience Corp is $703,972. There are 7 executives at Twist Bioscience Corp getting paid more, with Emily Leproust having the highest compensation of $8,126,160.
Mark Daniels is 57, he's been the Senior Vice President, Chief Legal Officer und Chief Ethics and Compliance Officer and Secretary of Twist Bioscience Corp since 2018. There are 9 older and 13 younger executives at Twist Bioscience Corp. The oldest executive at Twist Bioscience Corp is Dr. William Charles Banyai Ph.D., 66, who is the Sr. VP of Advanced Devel., GM of Data Storage & Director.
Mark's mailing address filed with the SEC is C/O TWIST BIOSCIENCE CORPORATION, 681 GATEWAY BLVD., SOUTH SAN FRANCISCO, CA, 94080.
Over the last 6 years, insiders at Twist Bioscience Corp have traded over $141,837,821 worth of Twist Bioscience Corp stock and bought 168,550 units worth $2,482,088 . The most active insiders traders include Fred B Craves, Keith Crandell und Emily M. Leproust. On average, Twist Bioscience Corp executives and independent directors trade stock every 8 days with the average trade being worth of $465,824. The most recent stock trade was executed by Dennis Cho on 6 September 2024, trading 275 units of TWST stock currently worth $10,769.
at twist bioscience, our expertise is synthetic dna. we have developed a proprietary semiconductor-based synthetic dna manufacturing process featuring a 10,000-well silicon platform capable of producing synthetic biology tools, such as oligonucleotides, genes, pathways, chassis and genomes. by synthesizing dna on silicon instead of on traditional 96-well plastic plates, our platform overcomes the current inefficiencies of synthetic dna production, and enables cost-effective, rapid, high-quality and high throughput synthetic gene production. the twist bioscience platform has the potential to greatly accelerate the development of personalized medicine, sustainable chemical production, improved agriculture production as well as new applications such as in vivo diagnostics, biodetection and data storage. for more information, please visit www.twistbioscience.com .
Twist Bioscience Corp executives and other stock owners filed with the SEC include: